Navigation Links
Solos Endoscopy, Inc. Reports Significant Sales From Its MammoView® Instrument Line

BOSTON, Dec. 22, 2011 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company generated $27,455.52 and $30,103.00 in sales for the months of October and November 2011 respectively. Sales for the two month period were primarily driven by the Company's MammoView® Instrument line accounting for 38.9% of the $57,588.52 in sales revenue for October and November.

Total mammary ductoscopy sales increased 183% from $7925.00 in October to $14,490.00 in November. Solos' MammoView® Instrument line contains 13 different Breast Endoscopy Components which are all featured on the Company's website  The MammoView® instrument line, designed exclusively for breast endoscopy, has become crucial to early breast cancer screening as a method to significantly reduce breast cancer death rates.

"We had reported in August how pleased we were with the increase in demand for our MammoView instrument line," stated Bob Segersten, President of Solos Endoscopy, Inc. "The mammary ductoscopy sales in the third quarter as well as for October and November are something the Company will continue to build on as we enter 2012."

The Company recently announced that it finished the 3rd Quarter with a Net Profit of $73,895. Solos Endoscopy has consummated agreements which resulted in the Forgiveness of debt of $299,082 for the Three Months period ending September 30, 2011. The signed settlement agreement and new consulting agreement result in a reduction of ongoing expenses by approximately $40,000 per quarter.

About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Amanda Segersten,
Source: Solos Endoscopy, Inc.

SOURCE Solos Endoscopy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy Finishes the 3rd Quarter With a Net Profit
2. Solos Endoscopy Poised for Tremendous Growth in Multi-Billion Dollar Endoscopic Market
3. Solos Endoscopy Goes Google
4. Solos Endoscopy Finishes the 3rd Quarter Strong
5. Solos Endoscopy to Support National Breast Cancer Foundation With Sales of Its MammoView® Breast Endoscopy Components to US Hospitals
6. Solos Endoscopy to Market its MammoView® Breast Endoscopy Components to US Hospitals
7. Solos Endoscopy Reports 32% Increase in Breast Endoscopy Sales
8. Solos Endoscopy to Reduce Debt by Over $620,000
9. Solos Endoscopys MammoView® System Proves Crucial to Early Breast Cancer Detection
10. Lantus®/Apidra® SoloSTAR® Help to Improve Patient Satisfaction
11. Solos Endoscopy, Inc. To Launch New Corporate Website
Post Your Comments:
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with ... Latin America . ... ... ... ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 27, 2016 , ... TherapySites, the leading website ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to ... adding exclusive benefits and promotional offers. , "TCA is extremely excited about this ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
Breaking Medicine News(10 mins):